Tenaya Therapeutics Inc
Ownership
Ownership Structure
Who owns Tenaya Therapeutics Inc (TNYA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 94.4% of the shares are freely tradable; institutional investors hold 47.1%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Capital Management, LLC | 3.78 | 8,482,288 | +0.0 | 03/31/2026 |
| Millennium Management LLC | 2.87 | 6,429,648 | +17.8 | 06/30/2026 |
| Citadel Advisors Llc | 2.04 | 4,566,774 | +8.7 | 06/30/2026 |
| Kalehua Capital Management LLC | 1.78 | 4,000,000 | +100.0 | 03/31/2026 |
| Empery Asset Management, LP | 1.72 | 3,863,115 | -9.9 | 06/30/2026 |
| Renaissance Technologies Corp | 1.66 | 3,713,761 | +100.6 | 03/31/2026 |
| BlackRock Inc | 1.65 | 3,703,955 | -6.2 | 03/31/2026 |
| Marshall Wace Asset Management Ltd | 1.21 | 2,705,390 | +92.4 | 03/31/2026 |
| GSA Capital Partners LLP | 1.19 | 2,669,033 | +148.8 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 2.29 | 5,136,220 | +0.0 | 08/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Ali Faraz | Chief Executive Officer | 539,782 | 305,355 $ | Sep 10, 2026 | direct |
| Tingley Whittemore | Chief Medical Officer | 263,073 | 148,820 $ | Sep 10, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 10, 2026 | Ali Faraz | Chief Executive Officer | Other | 122,000 | 0.00 | – |
| Sep 10, 2026 | Tingley Whittemore | Chief Medical Officer | Other | 49,000 | 0.00 | – |
| Aug 17, 2026 | Ali Faraz | Chief Executive Officer | Sell | 7,406 | 0.7097 | 5,256 |
| Aug 17, 2026 | Ali Faraz | Chief Executive Officer | Sell | 5,020 | 0.7097 | 3,563 |
| Aug 17, 2026 | Ali Faraz | Chief Executive Officer | Sell | 3,969 | 0.7098 | 2,817 |
| Aug 17, 2026 | Ali Faraz | Chief Executive Officer | Sell | 5,837 | 0.7097 | 4,143 |
| Aug 17, 2026 | Tingley Whittemore | Chief Medical Officer | Sell | 2,279 | 0.7098 | 1,618 |
| Aug 17, 2026 | Tingley Whittemore | Chief Medical Officer | Sell | 1,871 | 0.7098 | 1,328 |
| Aug 17, 2026 | Tingley Whittemore | Chief Medical Officer | Sell | 1,637 | 0.7098 | 1,162 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.